Table 4. Clinical characterization of Jardinópolis patients regarding the percentage of positivity to the clinical criteria used for the diagnosis of leprosy (n = 64).
| Clinical features | LG (n = 64) | % | |||
|---|---|---|---|---|---|
| Dysesthesia hypochromic macular skin lesions | 64 | 100 | |||
| Localized irregular patches of circumscribed hair loss | 13 | 20.3 | |||
| Altered nerves on palpation (enlargement and/or pain and/or electric shock-like pain) | 46 | 71.9 | |||
| Endogenous histamine test performed | 32 | 100 | |||
| Incomplete | 32 | 100 | |||
| Esthesiometry of hands | 57 | 89.1 | |||
| Normal | 31 | 54.4 | |||
| Abnormal | 26 | 45.6 | |||
| Esthesiometry of feet | 57 | 89.1 | |||
| Normal | 8 | 14.0 | |||
| Abnormal | 49 | 86.0 | |||
| Leprosy classification | |||||
| Borderline | 64 | 100 | |||
| WHO operational criteria | |||||
| Multibacillary | 64 | 100 | |||
| WHO impairment grading | |||||
| Grade 0 | 18 | 28.1 | |||
| Grade 1 | 30 | 46.9 | |||
| Grade 2 | 8 | 12.5 | |||
| Not evaluated | 8 | 12.5 | |||
| BCG scar | NLG | % | LG | % | |
| 0 | 67 | 16.1 | 12 | 18.8 | |
| 1 | 324 | 78.1 | 51 | 79.7 | |
| ≥ 2 | 11 | 2.7 | 1 | 1.6 | |
| Not evaluated | 13 | 3.1 | - | ||
BCG: Bacillus Calmette–Guérin; LG: Leprosy group; WHO: World Health Organization.